Cancer drugs to help Cipla sales hit $7 billion – Livemint
![]() Livemint |
Cancer drugs to help Cipla sales hit $7 billion
Livemint India’s third-largest drug maker by market value predicts revenue may rise to as much as $7 billion (around Rs.38,122 crore) selling medicines in the continent that’s home to about 800 million people, said Chandru Chawla, head of international business … |